Form 4 for CRL Charles River Laboratories
Accepted 2024-05-28 00:00:00 ET · period of report 2024-05-26 · accession 0001127602-24-016726 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-05-28 | 2024-05-26+ | CRL | LaPlume Joseph W | EVP, Corp Strategy, Develop | F - Tax | $217.21 | -552 | 23.0K | -2% | -$119.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-27 | F | D | 184 | $217.21 | 22,849 | D | — | — | |
| 2 | Common | Common Stock | 2024-05-28 | F | D | 125 | $217.21 | 22,724 | D | — | — | |
| 3 | Common | Common Stock | 2024-05-26 | F | D | 243 | $217.21 | 23,033 | D | — | — |